Jan 10, 2022 / 06:30PM GMT
David A. Low - J.P. Morgan Chase & Co, Research Division - Research Analyst
Hello, everyone. My name is David Low. I cover healthcare companies for -- the Australian Healthcare companies for J.P. Morgan. Today, we've got Mick Farrell, CEO of ResMed with us. Just before I hand over to Mick, just a reminder that you can ask questions at any time you can submit questions at any time via the website. We'll have a Q&A session after Mick finished his presentation. So thanks very much, Mick. Over to you.
Michael J. Farrell - ResMed Inc. - CEO & Director
Thanks, David, and thank you to everybody joining us here on the virtual J.P. Morgan session here this morning, California time. I'm going to start on Slide 4 of my presentation deck, which is entitled ResMed: The Global Leader in Connected and Digital Health. And I'll move pretty quickly through the document about 20 minutes of presentation, and then we'll open up for 20 minutes of Q&A, where I'll be joined by Rob Douglas, our President and COO; and Dave Pendarvis, our Global Chief Administrative Officer
Resmed Inc at J.P. Morgan Healthcare Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers